Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

Celsion

ClinicalTrials.gov Identifier:

NCT00617981

First received: February 6, 2008

Last updated: February 3, 2014

Last verified: February 2014

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2015
Primary Completion Date:	January 2013 (Final data collection date for primary outcome measure)